Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Comparison of Early Postoperative Functional Capacity and Kinesiophobia in Patients Undergoing Thoracic Surgery Via Thoracotomy or VATS

10 de junio de 2026 actualizado por: Funda Alma, Hacettepe University

Comparison of Early Postoperative Functional Capacity, Kinesiophobia, Pain, Dyspnea, Fatigue, and Anxiety in Patients Undergoing Thoracic Surgery Via Thoracotomy or Video-Assisted Thoracic Surgery

This observational cross-sectional study aims to compare early postoperative functional capacity and kinesiophobia in patients undergoing thoracic surgery via thoracotomy or video-assisted thoracic surgery (VATS). Patients aged 18-75 years who underwent thoracic surgery and agreed to participate will be evaluated during the early postoperative period, after chest tube removal and before hospital discharge.

Functional capacity will be assessed using the 1-minute sit-to-stand test. Kinesiophobia will be evaluated using the Tampa Scale for Kinesiophobia. Pain, dyspnea, fatigue, and coronavirus-related anxiety will also be assessed using validated scales and questionnaires. The study will investigate the relationship between kinesiophobia and postoperative functional and symptom-related outcomes.

Descripción general del estudio

Estado

Terminado

Descripción detallada

Thoracic surgical procedures may lead to postoperative pain, reduced mobility, impaired functional capacity, and fear of movement. Thoracotomy involves opening the chest wall and is associated with greater surgical trauma, whereas video-assisted thoracic surgery (VATS) is a minimally invasive surgical approach performed through smaller incisions without rib spreading. VATS is generally associated with lower morbidity, shorter hospital stay, and earlier return to physical activity.

Kinesiophobia, defined as an excessive and irrational fear of movement or re-injury, may negatively affect postoperative recovery and rehabilitation participation. Although kinesiophobia has been widely investigated in musculoskeletal and chronic pain conditions, there is limited evidence regarding its role after thoracic surgery.

The aim of this study is to evaluate early postoperative functional capacity, kinesiophobia, and factors associated with kinesiophobia in patients undergoing thoracic surgery via thoracotomy or VATS. Eligible patients will be assessed in the early postoperative period, after removal of chest tubes and before discharge, corresponding approximately to postoperative days 2-10.

Demographic and clinical data will be recorded. Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia. Functional capacity will be evaluated using the 1-minute sit-to-stand test. Pain will be assessed using the McGill-Melzack Pain Questionnaire. Dyspnea and fatigue will be evaluated using the Modified Borg Scale. Coronavirus-related anxiety will be assessed using the Coronavirus Anxiety Scale Short Form.

Tipo de estudio

De observación

Inscripción (Actual)

18

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Altındağ
      • Ankara, Altındağ, Turquía (Türkiye), 06100
        • Hacettepe University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

Patients aged 18-75 years who underwent thoracic surgery via thoracotomy or video-assisted thoracic surgery at the Department of Thoracic Surgery, Hacettepe University, and agreed to participate in the study.

Descripción

Inclusion Criteria:

  • Undergoing thoracic surgery via thoracotomy or video-assisted thoracic surgery
  • Aged between 18 and 75 years
  • Volunteering to participate in the study
  • Providing informed consent

Exclusion Criteria:

  • Presence of cooperation or communication problems that prevent assessment
  • History of previous thoracic surgery

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Thoracotomy Group
Patients aged 18-75 years who underwent thoracic surgery via thoracotomy and agreed to participate in the study.
VATS Group
Patients aged 18-75 years who underwent thoracic surgery via video-assisted thoracic surgery and agreed to participate in the study.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Kinesiophobia
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia. The scale consists of 17 items scored on a 4-point Likert scale. Total scores range from 17 to 68, with higher scores indicating greater fear of movement.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Functional Capacity
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Functional capacity will be assessed using the 1-minute sit-to-stand test. The number of full sit-to-stand repetitions completed in one minute will be recorded.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Pain Level
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Pain will be evaluated using the McGill-Melzack Pain Questionnaire, which assesses pain location, quality, temporal characteristics, and intensity.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Dyspnea
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Dyspnea severity will be assessed using the Modified Borg Scale, a 0-10 category-ratio scale, with higher scores indicating greater perceived dyspnea.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Fatigue
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Fatigue severity will be assessed using the Modified Borg Scale, a 0-10 category-ratio scale, with higher scores indicating greater perceived fatigue.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Coronavirus-related Anxiety
Periodo de tiempo: Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10
Coronavirus-related anxiety will be assessed using the Coronavirus Anxiety Scale Short Form.
Early postoperative period, after chest tube removal and before hospital discharge, approximately postoperative days 2-10

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de mayo de 2021

Finalización primaria (Actual)

1 de mayo de 2022

Finalización del estudio (Actual)

1 de julio de 2022

Fechas de registro del estudio

Enviado por primera vez

10 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de junio de 2026

Publicado por primera vez (Actual)

15 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • GO 20/1155

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir